Prophylactic anticoagulation for patients in hospital with covid-19

BMJ. 2021 Feb 19:372:n487. doi: 10.1136/bmj.n487.

Authors

Beverley J Hunt¹, Erich V De Paula², Claire McLintock³, Mert Dumantepe⁴

Affiliations

¹ Thrombosis and Haemophilia Centre, Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK Beverley.hunt@gstt.nhs.uk.
² School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil.
³ Maternal-Fetal Medicine Service, National Women's Health, Auckland City Hospital, Auckland, New Zealand.
⁴ Department of Cardiovascular Surgery, School of Medicine, University of Uskudar, Istanbul, Turkey.

PMID: 33608304
DOI: 10.1136/bmj.n487

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anticoagulants / therapeutic use
COVID-19*
Cohort Studies
Hospitals
Humans
SARS-CoV-2
United States

Substances

Anticoagulants